• Asthma/COPD

Asthma/COPD:

Indications for INCRUSE ELLIPTA:

Maintenance treatment of COPD.

Adult:

Take at same time every day. 1 inhalation every 24hrs.

Children:

Not established.

Contraindications:

Severe hypersensitivity to milk proteins.

Warnings/Precautions:

Not indicated for relief of acute bronchospasm. Do not initiate in rapidly or acutely deteriorating COPD. Do not exceed recommended dose. Reevaluate periodically. Prescribe a short-acting, inhaled β2-agonist for acute symptoms; monitor for increased need. Discontinue if paradoxical bronchospasm (use alternatives) or hypersensitivity reactions occur. Narrow-angle glaucoma. Urinary retention. Prostatic hyperplasia. Bladder-neck obstruction. Severe hepatic impairment. Pregnancy. Nursing mothers.

Pharmacologic Class:

Anticholinergic.

Interactions:

Additive effects with concomitant other anticholinergic-containing drugs; avoid.

Adverse Reactions:

Nasopharyngitis, URTI, cough, arthralgia; visual disturbances, paradoxical bronchospasm.

Generic Availability:

NO

How Supplied:

Dry pwd inhaler—30 doses

Pricing for INCRUSE ELLIPTA

30 blisters of 62.5mcg inhaler (Qty: 1)
Appx. price $339
GoodRx